Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1995 1
2001 1
2003 1
2004 1
2005 3
2006 1
2007 1
2010 1
2012 1
2013 2
2014 2
2015 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Tumor Targeting with an isoDGR-Drug Conjugate.
Zanella S, Angerani S, Pina A, López Rivas P, Giannini C, Panzeri S, Arosio D, Caruso M, Gasparri F, Fraietta I, Albanese C, Marsiglio A, Pignataro L, Belvisi L, Piarulli U, Gennari C. Zanella S, et al. Among authors: Marsiglio A. Chemistry. 2017 Jun 12;23(33):7910-7914. doi: 10.1002/chem.201701844. Epub 2017 May 26. Chemistry. 2017. PMID: 28449309 Free PMC article.
β-Blockers and cardiac protection.
Bolsin SN, Marsiglio A, Colson M. Bolsin SN, et al. Among authors: Marsiglio A. Br J Anaesth. 2014 Oct;113(4):721-2. doi: 10.1093/bja/aeu288. Br J Anaesth. 2014. PMID: 25236900 Free article. No abstract available.
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Donati D, Gennari C. Dal Corso A, et al. Among authors: Marsiglio A. Chemistry. 2015 Apr 27;21(18):6921-9. doi: 10.1002/chem.201500158. Epub 2015 Mar 17. Chemistry. 2015. PMID: 25784522
Beta-blockade and noncardiac surgery.
Bolsin SN, Colson M, Marsiglio A. Bolsin SN, et al. Among authors: Marsiglio A. J Cardiothorac Vasc Anesth. 2014 Jun;28(3):e25-6. doi: 10.1053/j.jvca.2014.01.013. Epub 2014 Mar 27. J Cardiothorac Vasc Anesth. 2014. PMID: 24685361 No abstract available.
Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.
Casuscelli F, Ardini E, Avanzi N, Casale E, Cervi G, D'Anello M, Donati D, Faiardi D, Ferguson RD, Fogliatto G, Galvani A, Marsiglio A, Mirizzi DG, Montemartini M, Orrenius C, Papeo G, Piutti C, Salom B, Felder ER. Casuscelli F, et al. Among authors: Marsiglio A. Bioorg Med Chem. 2013 Dec 1;21(23):7364-80. doi: 10.1016/j.bmc.2013.09.054. Epub 2013 Oct 2. Bioorg Med Chem. 2013. PMID: 24139169
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.
Pevarello P, Brasca MG, Orsini P, Traquandi G, Longo A, Nesi M, Orzi F, Piutti C, Sansonna P, Varasi M, Cameron A, Vulpetti A, Roletto F, Alzani R, Ciomei M, Albanese C, Pastori W, Marsiglio A, Pesenti E, Fiorentini F, Bischoff JR, Mercurio C. Pevarello P, et al. Among authors: Marsiglio A. J Med Chem. 2005 Apr 21;48(8):2944-56. doi: 10.1021/jm0408870. J Med Chem. 2005. PMID: 15828833
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time.
Germani M, Magni P, De Nicolao G, Poggesi I, Marsiglio A, Ballinari D, Rocchetti M. Germani M, et al. Among authors: Marsiglio A. Cancer Chemother Pharmacol. 2003 Dec;52(6):507-13. doi: 10.1007/s00280-003-0688-7. Epub 2003 Aug 16. Cancer Chemother Pharmacol. 2003. PMID: 12923660
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding.
Pevarello P, Brasca MG, Amici R, Orsini P, Traquandi G, Corti L, Piutti C, Sansonna P, Villa M, Pierce BS, Pulici M, Giordano P, Martina K, Fritzen EL, Nugent RA, Casale E, Cameron A, Ciomei M, Roletto F, Isacchi A, Fogliatto G, Pesenti E, Pastori W, Marsiglio A, Leach KL, Clare PM, Fiorentini F, Varasi M, Vulpetti A, Warpehoski MA. Pevarello P, et al. Among authors: Marsiglio A. J Med Chem. 2004 Jun 17;47(13):3367-80. doi: 10.1021/jm031145u. J Med Chem. 2004. PMID: 15189033
Perioperative β blockade.
Bolsin S, Colson M, Marsiglio A. Bolsin S, et al. Among authors: Marsiglio A. BMJ. 2013 Sep 19;347:f5640. doi: 10.1136/bmj.f5640. BMJ. 2013. PMID: 24052587 No abstract available.
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.
Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D, Moll J. Carpinelli P, et al. Among authors: Marsiglio A. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3158-68. doi: 10.1158/1535-7163.MCT-07-0444. Mol Cancer Ther. 2007. PMID: 18089710 Free article.
19 results
Jump to page
Feedback